Related Experiment Video
Updated: Jun 8, 2026

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
The NC1 domain of type XIX collagen inhibits melanoma cell migration
Aida Toubal1, Laurent Ramont, Christine Terryn
1Université de Reims Champagne-Ardenne, 51095 Reims, France.
Abstract:
Type XIX collagen is a minor collagen that localizes to basement membrane zones. We previously demonstrated that the C-terminal NC1 domain of type XIX collagen inhibits tumor growth in vivo. In the present study, we analyzed the effects of the NC1(XIX) collagen domain on migratory behaviour of melanoma B16F10 cells. We found that NC1(XIX) do not inhibit melanoma cell proliferation. On the contrary, NC1(XIX) strongly inhibited the migratory capacities of melanoma cells in the scratch wound model and in Ibidi® devices: cell migration speed was 7.69 ± 1.49 μm/h for the controls vs 6.64 ± 0.82 μm/h for cells incubated with 30 μmol/L NC1(XIX) and 5.72 ± 0.67 μmol/h with 60 μmol/L NC1(XIX). Similar results were obtained with UACC 903 human melanoma cells. Further work will be necessary to elucidate the molecular mechanisms of this migration inhibition. It may, however, explain, at least partially, the inhibition of tumor growth that we observed in vivo.
Insights
The NC1 domain of type XIX collagen inhibits melanoma cell migration, not proliferation. This finding may help explain how this collagen domain slows tumor growth.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Type XIX collagen is a minor collagen found in basement membrane zones.
- The C-terminal NC1 domain of type XIX collagen (NC1(XIX)) has previously shown in vivo tumor growth inhibition.
Purpose of the Study:
- To investigate the effects of the NC1(XIX) collagen domain on melanoma cell migratory behavior.
- To determine if NC1(XIX) impacts melanoma cell proliferation.
Main Methods:
- Melanoma cell lines (B16F10 and UACC 903) were treated with varying concentrations of NC1(XIX).
- Cell proliferation assays were performed.
- Cell migration was assessed using the scratch wound model and Ibidi® devices.
Main Results:
- NC1(XIX) did not inhibit melanoma cell proliferation.
- NC1(XIX) significantly reduced melanoma cell migration speed in a dose-dependent manner.
- Reduced migration was observed in both murine (B16F10) and human (UACC 903) melanoma cells.
Conclusions:
- The NC1(XIX) domain inhibits melanoma cell migration.
- This anti-migratory effect may contribute to the previously observed inhibition of tumor growth.
- Further research is needed to elucidate the underlying molecular mechanisms of migration inhibition.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Migration
Cell Migration
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
